Brain 18-FDG PET scan in central nervous system Langerhans cell histiocytosis

Journal of Pediatrics

Volumn 141, Issue 3, 2002, Pages 435-440

  Calming, Ulrika ^a   Bemstrand, Cecilia ^a   Mosskin, Mikael ^a   Elander, Sharon Stone ^a   Ingvar, Martin ^a   Henter, Jan Inge ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; LANGERHANS CELL; MALE; MENTAL DISEASE; NEUROENDOCRINE DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0036732575     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.127087     Document Type: Article

References (24)

1. Langerhans cell histiocytosis
2. The histiocytoses
3. Langerhans cell histiocytosis - Clinical and epidemiological aspects
4. Langerhans cell histiocytosis (Histiocytosis X): A clonal proliferative disease
5. Diabetes insipidus associated with Langerhans cell histiocytosis: Is it reversible?
6. Central nervous system disease in Langerhans cell histiocytosis
7. Central nervous system in Langerhans cell histiocytosis
8. Central nervous system disease associated with Langerhans cell histiocytosis
9. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study
10. Central nervous system disease in Langerhans cell histiocytosis
11. Disease course and late sequelae of Langerhans cell histiocytosis: 25-year experience at the University of California, San Francisco
12. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET)
13. Positron emission tomography in patients with primary CNS lymphomas
14. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
15. Imaging of oncologic patients: Benefit of combined CT and FDG PET in the diagnosis of malignancy
16. The FDG/PET methodology for early detection of disease onset: A statistical model
17. Introduction to imaging brain tumor metabolism with positron emission tomography (PET)
18. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy
19. Brain MR in patients with Langerhans cell histiocytosis: Findings and enhancement with Gd - DTPA
20. Disseminated cerebral histiocytosis X responding to vinblastine therapy: A case report
21. Radiation therapy in the management of Langerhans cell histiocytosis
22. Cerebellar involvement in multifocal eosinophilic granuloma: Demonstration by computerized tomographic scanning
23. Predominantly cerebral forms of Histiocytosis-X
24. Circulation through special regions